TriSalus Life Sciences announces collaboration with CU Anschutz
TriSalus Life Sciences has entered a strategic research collaboration with the University of Colorado Anschutz Medical Campus (CU Anschutz). The collaboration will leverage TriSalus' immunotherapy platform, which integrates immunotherapeutics and drug delivery technology, to address the unique challenges of treating tumors in the liver and pancreas. Read More
Pluristyx, Pancella, Implant Therapeutics announce strategic alliance
Pluristyx, Pancella, and Implant Therapeutics have entered into a manufacturing and distribution strategic alliance that offers cell therapy companies streamlined access to the next generation of safe, universal, cost-effective, "off-the-shelf" induced pluripotent stem cells. Read More
Colorcon Ventures invests in Apprentice
Colorcon Ventures has invested in Apprentice, a provider of intelligent manufacturing execution systems designed specifically for the life sciences industry. Apprentice offers a dynamic, end-to-end platform with software applications that are designed to streamline batch-based manufacturing and remote collaboration. Read More
Eikonoklastes bolsters pipeline
Eikonoklastes Therapeutics has completed a license agreement with the University of California, San Diego to add a novel gene therapy for the treatment of neurodegenerative diseases, including a potential treatment for Lou Gehrig's disease, or amyotrophic lateral sclerosis. Read More
Excelra partners with XtalPi
Excelra has partnered its Global Online Structure Activity Relationship Database with XtalPi, an artificial intelligence-based pharmaceutical biotechnology company, to reinvent the industry's approach to drug R&D. Read More
64x Bio gains funding to advance cell line engineering platform
64x Bio, a synthetic biology company, announced the close of a $55 million series A financing round to fund the expansion of VectorSelect, the company's cell line engineering platform. Read More
ONI closes $75M series B funding
ONI, known for the Nanoimager microscopy platform, closed a $75 million series B financing round. The proceeds will be used to grow ONI's commercial and R&D teams in the U.S. and Asia, driving technology adoption in those geographies. Read More
Single Cell Discoveries and BioTuring advance single-cell sequencing
Single Cell Discoveries and BioTuring have formed a collaboration to improve single-cell sequencing research. As part of the collaboration, Single Cell Discoveries will add BioTuring's data analysis solution to its sequencing services. Read More
Charles River, Valo Health announce strategic partnership
Charles River Laboratories and Valo Health have formed a multiyear strategic partnership to offer a transformative, artificial intelligence-enabled drug discovery and development platform. Read More
Bruker acquires Prolab Instruments
Bruker has acquired Prolab Instruments, a company that specializes in low-flow, high-precision liquid chromatography technology and systems. The acquisition will complement Bruker's scientific instruments and analytical and diagnostic solutions. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
